-
Deciphera had another bidder before Ono deal; Bristol Myers reports Ph3 fail in lung cancer
13 May 2024 14:56 GMT
… in April. — Max Gelman
Bristol Myers Squibb reports lung cancer failure: The …
-
Bristol Myers Squibb's phase 3 CheckMate ─73L trial in unresectable, locally advanced stage III NSCLC fails to meet primary endpoint
13 May 2024 05:00 GMT
… program lead, thoracic cancers, Bristol Myers Squibb. “There remains a critical … survival expectations for many, Bristol Myers Squibb researchers are exploring new frontiers … with Ono Pharmaceutical Co., Bristol Myers Squibb expanded its territorial rights …
-
Is Bristol Myers' Dividend in Danger?
11 May 2024 11:36 GMT
Bristol Myers Squibb (BMY 0.45%) pays … to rising competition.
Is Bristol Myers generating enough profit to …
Should you invest in Bristol Myers stock?
Bristol Myers' dividend … has positions in and recommends Bristol Myers Squibb. The Motley Fool has …
-
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
10 May 2024 20:48 GMT
… survival expectations for many, Bristol Myers Squibb researchers are exploring new … Hodgkin lymphoma.
About the Bristol Myers Squibb and Ono Pharmaceutical Collaboration … and Taiwan.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical …
-
FDA Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
10 May 2024 17:03 GMT
Bristol Myers Squibb announced that the FDA accepted … president, global program lead, Bristol Myers Squibb. “Opdivo is a foundational PD …
-
SEQUOIA-HCM trial meets primary endpoint in obstructive hypertrophic cardiomyopathy
13 May 2024 13:17 GMT
… from Abbott, Beckman, Bristol Myers Squibb, Boehringer Ingelheim, Janssen, … AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardior, Cardurion, Corvia, … , AstraZeneca, Bellerophon, Bayer, Bristol Myers Squibb, Celladon, Cytokinetics, Eidos, …
-
Biotech sees more job cuts
13 May 2024 12:11 GMT
… weeks, with Gilead, Freenome, Bristol Myers Squibb and PacBio most recently announcing … workforces, facilities or both. Bristol Myers Squibb’s layoff notice is also …
-
RNA Targeting Small Molecule Drug Discovery Market Size, Share, Revenue, Trends And Drivers For 2024-2033
13 May 2024 14:00 GMT
… , Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC.
RNA Targeting …
-
Fibrosarcoma Drugs Market Share, Application Analysis, Regional Outlook, Competitive Strategies and Forecast
13 May 2024 11:50 GMT
… this report:
Cadila Healthcare Limited, Bristol-Myers Squibb Company, Dr. Reddy…
-
ReCode Therapeutics Announces Appointment of Dean J. Mitchell as Chairman of Its Board of Directors
13 May 2024 11:39 GMT
… previously held executive roles at Bristol Myers Squibb and GlaxoSmithKline. Mr. Mitchell …